Nauru vs South Asia: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Nauru
- South Asia
How they compare
Nauru currently reports 34.8% against 23.6% in South Asia, a difference of 11.2%.
That makes Nauru's figure about 1.5 times South Asia's.
Across all 9 years both countries report, Nauru has been ahead every year.
Nauru ranks 14th and South Asia ranks 11th of 166 countries.
Nauru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nauru | South Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.3% | 48.6% | 10.7% | Nauru |
| 2010s | 47.1% | 35.6% | 11.5% | Nauru |
| 2020s | 36.4% | 25.1% | 11.3% | Nauru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Nauru or South Asia?
- Nauru, at 34.8% against 23.6% in South Asia as of 2024.
- What is the difference in prevalence of current tobacco use between Nauru and South Asia?
- 11.2%, with Nauru ahead.
- How many years of comparable data are there for Nauru and South Asia?
- 9 years are reported by both, from 2000 to 2024.
- How do Nauru and South Asia rank globally for prevalence of current tobacco use?
- Nauru ranks 14th and South Asia ranks 11th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.